You are about to leave jnjmedtech.com. By clicking to continue, you will be taken to a web site governed by their own Legal and Privacy Policies.
TRAUMACEM™ V+ Injectable Bone Cement
TRAUMACEM™ V+ Injectable Bone Cement
TRAUMACEM™ V+ Injectable Bone Cement is a viscous PMMA cement. Its special composition allows immediate use after mixing, provides a long working time at room temperature and is radio-opaque for enhanced visual control during application.
Features & Benefits
Ready-to-use After Mixing
Cement requires no waiting time before injectable viscosity is reached.
Long Working Time
The working time for TRAUMACEM V+ Injectable Bone Cement at room temperature (20 °C) is approximately 27 minutes. Includes an 8-gauge cannula, 15 cm to offer stress reduction for surgeon and operating staff during application.
Radio-opaque
Visual control during application.
Complete Modular System
Decision to augment (with PFNA Augment, TFNA Augment and Philos Augment) can be made intraoperatively.
Supporting Documentation
Surgical Technique Guides
Request Sales Rep
If you wish to learn more about this product, submit a request and a representative of DePuy Synthes will be in touch shortly.
Request Brochure
If you require a printed or digital brochure or surgical technique for this product, submit your request and we will send it to you.
Other Requests
Have a different kind of query? Simply fill out the details of your request and we will get back to you as soon as possible.
References
For product details such as indications, contraindications, warnings and precautions please consult the IFU and Surgical Technique.
Indications
The TRAUMACEM V+ Injectable Bone Cement is indicated for osteoporotic fractures of the upper and lower extremities in combined procedures with internal fixation devices intended for PMMA augmentation.
108357-210609
© DePuy Synthes Companies 2021. All Rights Reserved.
This site is published by the DePuy Synthes Companies, which are solely responsible for its content.
This site is for visitors from Europe, Middle East and Africa.
The third party trademarks used herein are trademarks of their respective owners.